Healthcare
Live Price
Offline$8.27
+4.03% today
1Y Change
+151.58%
Window
Jun 30, 2025 → Jun 25, 2026
Coverage: 248 bars · Jun 30, 2025 → Jun 25, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Burning Rock Biotech Limited (BNR) is a Healthcare stock with a market cap of $130.00M. The stock last traded around $8.27 and up 151.6% across the available one-year price window (Jun 30, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of +1.8%, EPS growth of -47.3%, a dividend yield of 0.0%. What stands out right now is revenue +1.8%, EPS -47.3%, free cash flow +65.7% with operating margin -10.2% and ROIC -9.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BNR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
BNR is 132.73 pts ahead over the shared 1Y window.
BNR had 73.72 pts deeper max drawdown than SPY.
BNR beat SPY in 1 of 2 calendar years shown and trailed in 1.
BNR
+151.58%
Normalized return
SPY
+18.85%
S&P 500
Excess Return
+132.73 pts
Relative to SPY
BNR Max Drawdown
-82.85%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for BNR and SPY.
| Year | BNR | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -59.60% | +6.71% | -66.31 pts | SPY |
| 2025 | +552.66% | +11.19% | +541.46 pts | BNR |
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.